Nootropics for productivity: what the evidence supports for work and study

Nobody runs a trial on "getting more done." Researchers measure narrower lab skills, and this hub groups those that matter for studying and focused work. The same outcomes sit on the focus and memory hubs, so the evidence matrix has no separate column for this goal; this page links those grades to practical guides.

• Attention covers sustained, selective and vigilance tasks. Trials used the psychomotor vigilance test [16], the d2 Test of Attention [34] and the Ruff 2&7 Selective Attention Test with a computerized performance test [13].
• Attention switching is accuracy when moving between two kinds of task, measured in trials of caffeine with L-theanine [9].
• Working memory is holding and updating information for seconds at a time, tested with tasks such as the N-Back test [27].
• Processing speed includes how fast people finish Trail Making Test part B [17].
• Executive function covers control and flexibility, tested with the Stroop test, which some trials score as attention [27], cognitive-flexibility tasks [12] and verbal fluency [29].
• Acute cognitive performance is a test battery given hours after a single dose, such as the Cognitive Demand Battery [20].
• Performance during sleep loss repeats these tests during extended wakefulness, such as 21 hours without sleep [16].
• Mental fatigue is rated by participants themselves on fatigue scales, as in the ginseng trials pooled in a 2023 meta-analysis [24].

This page puts the free basics first. The reviews below pooled studies that tested sleep, exercise and study methods directly.

Sleep. A meta-analysis of 70 articles containing 147 cognitive tests measured the effect of short-term (under 48 hours) total sleep deprivation on simple and complex attention, working memory, processing speed, short-term memory and reasoning, and found that the size of the effect differed between domains [1]. Effects ranged from small and nonsignificant for reasoning accuracy to large for lapses in simple attention [1].

Exercise. A 2025 meta-review of 30 systematic reviews (383 studies, 18,347 participants, from children to older adults with varied cognitive status) found that a single bout of exercise improved cognitive function with a small-to-medium effect (mean SMD = 0.33) [2]. Attention and executive function showed effects of similar size (mean SMD 0.37 and 0.36), and intensity, type and duration did not change the result [2].

Self-testing. A meta-analysis of 222 classroom studies with 48,478 students found that quizzing raised academic achievement to a medium extent (g = 0.499), compared with restudying and other strategies [3].

Spacing. A meta-analysis of 22 classroom reports found a moderate effect in favor of distributed over massed practice (d = 0.54) [4]. Effects tended to be larger at longer retention intervals and higher education levels [4].

Each grade below applies to one outcome, in the population the trials studied. Safety, interactions and who should be careful are covered on each compound's own page. See how we grade evidence for what each level requires.

Caffeine

In a 2025 meta-analysis of 31 randomized, double-blind, placebo-controlled trials in rested healthy adults (1,455 participants), caffeine improved attention accuracy (g = 0.27) and reaction time (g = 0.28) [5]. Accuracy improved only up to a certain dose before declining [5]. A 2005 review argued such studies may partly measure withdrawal reversal in regular users, finding little evidence of benefit from long-term use versus abstinence [7]; the 2025 meta-analysis found no link with habitual intake [5]. More on the caffeine page.

L-theanine (with caffeine)

A 2014 meta-analysis of 11 randomized placebo-controlled studies of tea constituents in healthy volunteers, some testing L-theanine with caffeine, found moderate effects in favor of the combination on alertness and attention-switching accuracy in the first 2 hours [8]. A 2025 meta-analysis in healthy participants, co-funded by Lipton Teas and Infusions and with authors employed by Lipton and Unilever, found better attention-switching accuracy with L-theanine plus caffeine (SMD 0.33), though its confidence intervals were often wide [9]. Trends suggested caffeine dose mattered more than L-theanine dose [8]. See L-theanine and the guide to caffeine and L-theanine.

L-tyrosine

A systematic review of 15 studies concluded that a single tyrosine load counteracted drops in working memory caused by demanding conditions such as extreme weather or cognitive load, in studies that were mostly single-session and small [10]. In a three-arm trial of 80 young adults during a stress drill, 2000 mg of L-tyrosine led to fewer missed responses on a Stroop challenge than placebo [11]. In 70 healthy volunteers, 2.0 g worsened cognitive flexibility under high load [12]. More on the L-tyrosine page.

Citicoline

In 75 healthy adolescent males, 28 days of citicoline (250 or 500 mg) improved attention compared with placebo, in a trial with three of seven authors affiliated with the ingredient supplier Kyowa Hakko [13]. In a 12-week trial in 100 healthy adults aged 50-85 with age-associated memory impairment, funded by Kyowa Hakko Bio, citicoline showed no significant effect on a sustained attention task after correction for multiple comparisons [14]. More on the citicoline page.

Creatine (during sleep loss)

In a crossover trial of 15 healthy young adults during 21 hours of sleep deprivation, a single 0.35 g/kg dose improved cognitive performance and processing speed compared with placebo [15]. A 2026 crossover trial of 29 healthy adults found a smaller dose (0.2 g/kg) reduced the decline in logic, number and vigilance tasks [16]. Both trials came from the same research group, were funded by Forschungszentrum Jülich and used a commercial AlzChem creatine product [15][16]. More on the creatine page.

Rhodiola rosea

A 2012 systematic review found that three of five randomized trials of mental fatigue reported a benefit, but every included study had a high risk of bias or reporting flaws [21]. In a registered 42-day trial of 48 nursing students on shift work, funded by the Government of Alberta, rhodiola worsened fatigue compared with placebo, a result the authors said should be interpreted with caution [22]. More on the Rhodiola rosea page.

Panax ginseng

A 2016 meta-analysis found reduced fatigue in four trials (SMD = 0.34) but judged the evidence insufficient [23]. A 2023 meta-analysis of 19 trials of ginseng and ginseng herbal formulas found no significant overall reduction in fatigue; in subgroups, fatigue fell with herbal formulas, in chronic fatigue and in general, non-disease fatigue (SMD -0.48), with small effect sizes [24]. Because the review pooled ginseng with multi-herb formulas, which showed the clearest benefit, the results cannot be credited to Panax ginseng alone [24]. The pooled trials enrolled people with fatigue, not healthy students or workers [24]. More on the Panax ginseng page.

Magnesium

In a 6-week trial funded by Threotech, which supplied the product and helped design the study, 100 adults aged 18-45 with dissatisfied sleep took 2 g a day of magnesium L-threonate (Magtein, 145 mg elemental magnesium) or placebo [25]. They improved more than the placebo group on an overall cognition composite (p = 0.043), with larger effects on working and episodic memory and no difference on Raven's test [25]. A 2024 meta-analysis found the 3 randomized trials it included insufficient to draw conclusions [26]. More on the magnesium page.

Cocoa flavanols

A 2026 meta-analysis of 16 randomized trials (2,847 participants) found faster Trail Making Test times and better verbal fluency with regular dark chocolate or cocoa intake, in trials that mixed healthy, older and clinical samples, while working-memory results were inconsistent [29]. In COSMOS-Mind, 2,262 older adults (mean age 73) took cocoa extract (500 mg/day of flavanols) or placebo for 3 years, and cocoa extract had no effect on an executive-function composite compared with placebo [30]. The parent COSMOS trial was supported by a grant from Mars Edge, which donated the study pills [30]. More on the cocoa flavanols page.

PQQ

In 41 healthy older adults, 20 mg a day of BioPQQ for 12 weeks produced a significantly smaller change in Stroop interference, a measure of selective attention, than placebo, in a trial with a co-author employed by Mitsubishi Gas Chemical, which makes the product [31]. A 12-week trial of 64 healthy Japanese adults aged 40 to under 80 who felt more forgetful (completers' mean age about 71), funded by and run by researchers employed by Ryusendo, reported better complex attention and cognitive flexibility scores at 21.5 mg a day [32]. As of November 11, 2026 we found no independent trial of PQQ for attention (PubMed search, November 11, 2026). More on the PQQ page.

Holy basil

A systematic review describes one randomized, double-blind trial in 40 healthy adults aged 18-30 who took 300 mg/day of tulsi leaf extract for 4 weeks [33]. Cognitive effects over placebo were significant only after the first two weeks [33]. The review does not name the tests; the holy basil page covers the trial's working-memory results. One review author is a paid consultant to Organic India, a maker of tulsi products [33]. More on the holy basil page.

Schisandra (in a combination)

In a pilot trial of 40 healthy women aged 20-68 who reported long-term stress, a single 270 mg tablet of ADAPT-232 improved attention, speed and accuracy on the d2 test 2 hours later compared with placebo (p<0.05) [34]. ADAPT-232 combines Rhodiola rosea, Schisandra chinensis and Eleutherococcus senticosus, so the result cannot be credited to schisandra alone [34]. More on the schisandra page.

Alpha-GPC

In a retrospectively registered crossover trial of 20 resistance-trained men, funded by the ingredient supplier NNB Nutrition and run by a paid adviser to the sponsor, single doses of 630 mg and 315 mg improved Stroop scores more than placebo (d = 0.61 and d = 0.48), with no differences on the Flanker or N-Back tests [27]. In a 7-day, four-arm trial of 48 college-aged men, funded by the ingredient supplier ChemiNutra, alpha-GPC showed no difference from placebo on psychomotor vigilance performance [28]. More on the alpha-GPC page.

Bacopa monnieri

A 2014 meta-analysis of 9 trials (518 participants) lasting 12 weeks or more, whose abstract does not separate healthy and impaired participants, found a shorter Trail B completion time in the 437 participants with data [17]. A 2026 network meta-analysis of 29 trials in healthy adults (2,107 participants) found no significant differences in sustained attention, selective attention or processing speed, though high-dose bacopa (600 mg/day or more) improved working memory compared with low dose and placebo, without direct comparisons [18]. After a single dose, 300 mg changed no test at 2 hours [19], while 320 mg improved some repetitions of a demanding battery in a trial co-funded by Soho Flordis International [20]. More on the Bacopa monnieri page.

Acetyl-L-carnitine

In 96 adults over 70 who met fatigue-syndrome criteria (a clinical, older population), acetyl-L-carnitine lowered mental-fatigue scores compared with placebo [35]; results may not apply to healthy adults. A Cochrane review of 5 trials (398 participants), all run by a single team in adults with cirrhosis and hepatic encephalopathy (a clinical population), found no clear difference in fatigue and rated the evidence very low quality [36]. More on the acetyl-L-carnitine page.

Huperzine A

In healthy young adults given a single 100 or 200 mcg dose (12 per group), huperzine A did not improve neurobehavioral performance compared with placebo, apart from maintained recall at the higher dose, which the authors attributed to likely ceiling effects in young, healthy participants [37]. In a crossover trial of 15 exercise-trained adults, a single 200 mcg dose changed no cognitive test compared with placebo [38]. More on the huperzine A page.

Ginkgo biloba

A meta-analysis of randomized trials in healthy people found effects close to zero and non-significant for attention (d = -0.08, 8 trials) and executive function (d = -0.05, 7 trials) [39]. The authors concluded that ginkgo had no ascertainable positive effects on these functions in healthy individuals [39]. More on the Ginkgo biloba page.

Mucuna pruriens

As of November 11, 2026 we found no randomized trials of Mucuna pruriens alone measuring attention or other cognitive tests in healthy adults (PubMed and Europe PMC searches, November 11, 2026). In a laboratory analysis of 16 US products, levodopa ranged from 2 mg to 241 mg per serving, was 228% to 2186% greater than the amount estimated from the label, and was undetectable in one product [40]. Safety and product quality are covered on the Mucuna pruriens page.

Guides for particular situations:

• Supplements for studying: exam periods and long revision sessions.
• Deep work routine: sleep, breaks and caffeine timing around focused blocks.
• Caffeine and L-theanine: what the combination trials measured.

Three 2026 papers bear on this goal. A smaller creatine dose still reduced sleep-loss decline, by up to 12% [16]. A network meta-analysis found no attention or processing-speed differences for bacopa or ginkgo, though high-dose bacopa improved working memory [18]. Cocoa trials in mixed samples showed faster Trail Making Test times [29].

What is the best nootropic for studying?

No trial we found compared supplements on exam results or real study sessions. In laboratory tests, caffeine improved attention in a meta-analysis of 31 placebo-controlled trials [5], while self-testing and spaced practice improved classroom learning in their own meta-analyses [3][4].

Do nootropics help with coding or programming?

As of November 11, 2026 we found no randomized trials of supplements in programmers or software developers (PubMed and Europe PMC search, November 11, 2026). The closest evidence is attention and working-memory testing in healthy adults, summarized above for each compound.

Is caffeine with L-theanine better than caffeine alone for focus?

No meta-analysis we cite compared the combination directly with caffeine alone. A 2014 meta-analysis found better attention-switching accuracy and alertness in the first 2 hours with the combination compared with placebo, and trends suggested caffeine dose mattered more than L-theanine dose [8]. A 2025 meta-analysis that reported similar findings was co-funded by Lipton Teas and Infusions [9].

Can caffeine for a late study session affect sleep?

In a meta-analysis of 24 studies, caffeine reduced total sleep time by 45 minutes [6]. The authors estimated that avoiding a reduction in total sleep time required a 250 mL coffee (107 mg of caffeine) to be consumed at least 8.8 hours before bedtime [6].